Objective To evaluate the role of continuous positive air pressure (CPAP) in the
management of respiratory failure associated with COVID-19 infection. Early clinical …

The aim of this case series is to describe and evaluate our experience of continuous positive
airway pressure (CPAP) to treat type 1 respiratory failure in patients with COVID-19. CPAP …

Background Continuous positive airway pressure (CPAP) ventilation may be used as a
potential bridge to invasive mechanical ventilation (IMV), or as a ceiling-of-care for persistent …

Abstract Introduction Throughout March–April 2020, many patients with COVID-19
presented to Southend University Hospital with Acute Hypoxaemic Respiratory Failure …

Introduction: Patients admitted with COVID-19 often have severe hypoxemic respiratory
insufficiency and it can be difficult to maintain adequate oxygenation with oxygen …

Aim We aimed to characterise a large population of coronavirus disease 2019 (COVID-19)
patients with moderate-to-severe hypoxaemic acute respiratory failure (ARF) receiving …

Background Continuous positive airway pressure (CPAP) therapy is commonly used for
respiratory failure due to severe COVID-19 pneumonitis, including in patients deemed not …

Introduction Because of the COVID-19 pandemic, intensive care units (ICU) can be
overwhelmed by the number of hypoxemic patients. Material and methods This single centre …

Objective The trial objective is to determine if Continuous Positive Airway Pressure (CPAP)
or High-Flow Nasal Oxygen (HFNO) is clinically effective compared to standard oxygen …

Since the beginning of March 2020, the coronavirus disease 2019 (COVID-19) pandemic
has caused more than 13,000 deaths in Europe, almost 54% of which has occurred in Italy …